Merrimack to Present at the Morgan Stanley Global Healthcare Conference
A live webcast of Merrimack's presentation can be accessed by visiting the Investors section of the company's website at investors.merrimackpharma.com. A replay of the webcast will be archived on Merrimack's website for two weeks following the presentation.
About Merrimack
Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies its systems biology-based approach to biomedical research throughout the research and development process. Merrimack currently has six oncology therapeutics in clinical development.
Forward-looking statements
Any statements in this press release about future expectations, plans and prospects for Merrimack constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially from those indicated by such forward-looking statements. Merrimack anticipates that subsequent events and developments will cause its views to change. However, while Merrimack may elect to update these forward-looking statements at some point in the future, Merrimack specifically disclaims any obligation to do so.
CONTACT: Investor Contact:
Geoffrey M. Grande , Merrimack
617-441-7602
ggrande@merrimackpharma.com
Media Contact:
Heather Gitlitz , Spectrum
202-955-6222
hgitlitz@spectrumscience.com
Source: News Provided by Acquire Media
